Scientists discover new 'off switch' in immune response

Scientists from Trinity College Dublin have discovered a new 'off switch' in our immune response which could be boosted in diseases caused by over-activation of our immune system, or blocked to improve vaccines. The findings are published this week in the journal Nature Communications. The research was funded by Health Research Board, Ireland and Science Foundation Ireland.

The research team, led by Dr Anne McGettrick and Professor Luke O'Neill, at the Trinity Institute, have discovered that a protein, called TMED7, can shut down part of our immune system once an infection has been eliminated. "Without stop signals like TMED7 our immune system would continue to rage out of control long after the infection has been cleared, leading to diseases such as ," says Dr Anne McGettrick. Manipulating these stop signals could help dampen down our immune system to prevent it attacking our own bodies.

In certain cases, removing stop signals and boosting our immune system can be advantageous. Several diseases such as Malaria and HIV are lacking good vaccines and research laboratories and drug companies around the world are looking to solve this problem. One major issue facing is the fact that our immune systems do not mount a strong enough to the , causing the vaccine to be ineffective. TMED7 limits a key process needed for vaccines to work involving a protein called TLR4. "Removing TMED7 from our cells could help boost our immune response to vaccines thus making the vaccines much more effective," says Dr Sarah Doyle, lead author on the publication.

TMED7 is part of a family of proteins and it is the first member of this family to be implicated in regulating our immune system. Interestingly, it is conserved through evolution and a version in fruit flies called logjam acts similarly to TMED7, limiting anti-bacterial responses. Further research will reveal if other members of this family play key roles in immunity, and this could lead to exciting new prospects for understanding our . The research was carried out in collaboration with the Norwegian University of Science and Technology, Trondheim, Norway.

Related Stories

Modified vaccine shows promise in preventing malaria

Sep 26, 2011

Continuing a global effort to prevent malaria infections, Michigan State University researchers have created a new malaria vaccine – one that combines the use of a disabled cold virus with an immune system-stimulating ...

Discovery of new vaccine approach for treatment of cancer

Dec 21, 2011

(Medical Xpress) -- Scientists in Trinity College Dublin, Ireland, have developed a new vaccine to treat cancer at the pre-clinical level. The research team led by Professor Kingston Mills, Professor of Experimental ...

Chemotherapy might help cancer vaccines work

May 16, 2008

Chemotherapy given in conjunction with cancer vaccines may boost the immune system’s response, potentially improving the effectiveness of this promising type of cancer therapy, according to a study by researchers in the ...

Recommended for you

Research reveals how lymph nodes expand during disease

Oct 22, 2014

Cancer Research UK and UCL scientists have discovered that the same specialised immune cells that patrol the body and spot infections also trigger the expansion of immune organs called lymph nodes, according to a study published ...

Protecting us from our cells

Oct 22, 2014

Our immune system defends us from harmful bacteria and viruses, but, if left unchecked, the cells that destroy those invaders can turn on the body itself, causing auto-immune diseases like type-1 diabetes ...

User comments